---
title: "Purple Biotech regains Nasdaq minimum bid price compliance"
url: "https://aibio.space/news/purple-biotech-regains-nasdaq-minimum-bid-price-compliance/"
publisher: "aibio.space (Biotech Investor Relations News)"
date: "2026-03-17"
section: "Listings"
tickers: "TASE:PPBT"
source: "https://www.sec.gov/Archives/edgar/data/1614744/000121390026028642/ea028196001ex99-1.htm"
summary: "The ADSs held a closing bid of $1.00 or more for at least 10 consecutive business days, reached on March 13, 2026. The company is now compliant with applic"
---

By the aibio.space news desk.

Sources

- [Purple Biotech Ltd. 6-K (2026-03-17)](https://www.sec.gov/Archives/edgar/data/1614744/000121390026028642/ea028196001ex99-1.htm)

[PPBT](https://aibio.space/companies/purple-biotech/)

2026-03-17

# Purple Biotech regains Nasdaq minimum bid price compliance

Tickers [PPBT](https://aibio.space/companies/purple-biotech/)

The ADSs held a closing bid of $1.00 or more for at least 10 consecutive business days, reached on March 13, 2026. The company is now compliant with applicable listing standards.

## Key facts

- **Company**: Purple Biotech Ltd. (TASE: PPBT)

- **News type**: Listings

- **Primary source**: [Purple Biotech Ltd. 6-K (2026-03-17)](https://www.sec.gov/Archives/edgar/data/1614744/000121390026028642/ea028196001ex99-1.htm)

*The Capitol dome against a blue sky. Photo: Carol M Highsmith, CC0, via rawpixel. The picture shows the field, not the companies named.*

Purple Biotech Ltd. said on March 17, 2026 that it received confirmation from the Listing Qualifications Department of The Nasdaq Stock Market LLC that it has regained compliance with the minimum bid price requirement. The rule is Nasdaq Listing Rule 5550(a)(2), which applies to continued listing on The Nasdaq Capital Market.

To regain compliance, the company had to keep a closing bid price for its American Depositary Shares (ADSs) of $1.00 per share or more for at least 10 consecutive business days. It reached that on March 13, 2026.

Purple Biotech says it is now compliant with the applicable listing standards for continued Nasdaq listing. The company's securities trade on both Nasdaq and the Tel Aviv Stock Exchange under the symbol PPBT.

[Report an error](https://aibio.space/reputation/#correction)

## Companies in this story

PPBT

Purple Biotech Ltd.

TASE · Israel

Open the starter desk

## More in Listings

Listings

### [Propanc Biopharma faces Nasdaq delisting on bid price, plans to appeal](https://aibio.space/news/propanc-biopharma-faces-nasdaq-delisting-bid-price-plans-appeal/)

Oct 29, 2026

Listings

### [Reviva asks stockholders to approve reverse split of up to 1-for-100](https://aibio.space/news/reviva-asks-stockholders-approve-reverse-split-up-1-100/)

Oct 29, 2026

Listings

### [Nasdaq to delist Glucotrack shares after bid price exception ends](https://aibio.space/news/nasdaq-delist-glucotrack-shares-after-bid-price-exception-ends/)

Oct 28, 2026

---
Source page: https://aibio.space/news/purple-biotech-regains-nasdaq-minimum-bid-price-compliance/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "Purple Biotech regains Nasdaq minimum bid price compliance", 2026-03-17, https://aibio.space/news/purple-biotech-regains-nasdaq-minimum-bid-price-compliance/